Prognostic impacts of tumoral expression and serum levels of PD-L1 and CTLA-4 in colorectal cancer patients

被引：0
|
作者：
Yusuke Omura
Yuji Toiyama
Yoshinaga Okugawa
Chengzeng Yin
Tsunehiko Shigemori
Kurando Kusunoki
Yukina Kusunoki
Shozo Ide
Tadanobu Shimura
Hiroyuki Fujikawa
Hiromi Yasuda
Junichiro Hiro
Masaki Ohi
Masato Kusunoki
机构：
[1] Mie University Graduate School of Medicine,Department of Gastrointestinal and Pediatric Surgery, Division of Reparative Medicine, Institute of Life Sciences
[2] Mie University Hospital,Department of Genomic Medicine
来源：
Cancer Immunology, Immunotherapy | 2020年 / 69卷
关键词：
Tumoral membrane expression; Soluble receptors and ligands; PD-L1; CTLA-4; Colorectal Cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2533 / 2546
页数：13
相关论文
共 50 条
  • [31] A phase II study of PD-L1 and CTLA-4 inhibition and immunopharmcogenomics in metastatic breast cancer
    Santa-Maria, C. A.
    Jain, S.
    Flaum, L.
    Park, J-H
    Kato, T.
    Gross, L.
    Uthe, R.
    Tellez, C.
    Stein, R.
    Rademaker, A.
    Gradishar, W. J.
    Nakamura, Y.
    Giles, F. J.
    Cristofanilli, M.
    CANCER RESEARCH, 2017, 77
  • [32] A Randomized Trial of Combined PD-L1 and CTLA-4 Inhibition with Targeted Low-Dose or Hypofractionated Radiation for Patients with Metastatic Colorectal Cancer
    Monjazeb, Arta M.
    Giobbie-Hurder, Anita
    Lako, Ana
    Thrash, Emily M.
    Brennick, Ryan C.
    Kao, Katrina Z.
    Manuszak, Claire
    Gentzler, Ryan D.
    Tesfaye, Anteneh
    Jabbour, Salma K.
    Alese, Olatunji B.
    Rahma, Osama E.
    Cleary, James M.
    Sharon, Elad
    Mamon, Harvey J.
    Cho, May
    Streicher, Howard
    Chen, Helen X.
    Ahmed, Mansoor M.
    Marino-Enriquez, Adrian
    Kim-Schulze, Seunghee
    Gnjatic, Sacha
    Maverakis, Emanual
    Marusina, Alina, I
    Merleev, Alexander A.
    Severgnini, Mariano
    Pfaff, Kathleen L.
    Lindsay, James
    Weirather, Jason L.
    Ranasinghe, Srinika
    Spektor, Alexander
    Rodig, Scott J.
    Hodi, Stephen F.
    Schoenfeld, Jonathan D.
    CLINICAL CANCER RESEARCH, 2021, 27 (09) : 2470 - 2480
  • [33] Prognostic value of the levels of CTLA-4 and its ligand B7.2 in patients with colorectal cancer
    Chetveryakov, A. V.
    Tsepelev, V. L.
    BYULLETEN SIBIRSKOY MEDITSINY, 2023, 22 (02): : 104 - 110
  • [34] Cancer vaccine formulation dictates synergy with CTLA-4 and PD-L1 checkpoint blockade therapy
    Hailemichael, Yared
    Woods, Amber
    Fu, Tihui
    He, Qiuming
    Nielsen, Michael C.
    Hasan, Farah
    Roszik, Jason
    Xiao, Zhilan
    Vianden, Christina
    Khong, Hiep
    Singh, Manisha
    Sharma, Meenu
    Faak, Faisal
    Moore, Derek
    Dai, Zhimin
    Anthony, Scott M.
    Schluns, Kimberly S.
    Sharma, Padmanee
    Engelhard, Victor H.
    Overwijk, Willem W.
    JOURNAL OF CLINICAL INVESTIGATION, 2018, 128 (04): : 1338 - 1354
  • [35] Cancer vaccine formulation dictates synergy with CTLA-4 and PD-L1 checkpoint blockade therapy
    Hailemichael, Yared
    Fu, Tihui
    Woods, Amber
    Roszik, Jason
    Schluns, Kimberly S.
    Engelhard, Victor H.
    Sharma, Padmanee
    Overwijk, Willem W.
    CANCER IMMUNOLOGY RESEARCH, 2016, 4 (11)
  • [36] The Potential Prognostic Impact and Intercorrelations between CTLA-4, PD-1/PD-L1 and CD73/A2AR Immune Checkpoint Molecules in Colorectal Cancer
    Aboelnasr, L.
    Abdou, A.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2023, 25 (11): : S140 - S141
  • [37] MicroRNAs as regulators of immune checkpoints in cancer immunotherapy: targeting PD-1/PD-L1 and CTLA-4 pathways
    Touchaei, Arefeh Zabeti
    Vahidi, Sogand
    CANCER CELL INTERNATIONAL, 2024, 24 (01)
  • [38] MicroRNAs as regulators of immune checkpoints in cancer immunotherapy: targeting PD-1/PD-L1 and CTLA-4 pathways
    Arefeh Zabeti Touchaei
    Sogand Vahidi
    Cancer Cell International, 24
  • [39] Revolutionization in Cancer Therapeutics via Targeting Major Immune Checkpoints PD-1, PD-L1 and CTLA-4
    Pandey, Pratibha
    Khan, Fahad
    Qari, Huda A.
    Upadhyay, Tarun Kumar
    Alkhateeb, Abdulhameed F.
    Oves, Mohammad
    PHARMACEUTICALS, 2022, 15 (03)
  • [40] Development of Plant-Derived Bispecific Monoclonal Antibody Targeting PD-L1 and CTLA-4 against Mouse Colorectal Cancer
    Bulaon, Christine Joy I.
    Khorattanakulchai, Narach
    Rattanapisit, Kaewta
    Sun, Hongyan
    Pisuttinusart, Nuttapat
    Phoolcharoen, Waranyoo
    PLANTA MEDICA, 2024, 90 (04) : 305 - 315
12345